1. Do patients wish us to share their information? 2. Do we ask our patients what they would like shared and with whom? 3. Do patients feel they should be involved in the decision to share information?
Methods
As this was an initial study we did not attempt a largescale audit at this stage. A random sample of 30 patients (11 males and 19 females) was selected between May and July 2006 in a care of the elderly acute assessment and rehabilitation hospital. All patients were either inpatients or medical day hospital attendees. The foci of the inpatient wards included general assessment and rehabilitation of older people, orthogeriatric rehabilitation, movement disorders and stroke medicine. The patients involved in the study were required to be cognitively intact. 
Results
Only one of the 30 patients had been asked by a doctor what information about their current illness they would like discussed with their family, next of kin or others. All of the patients were happy for doctors to discuss their condition with some other person, especially close relatives (Table 1) . Where discussion was approved, disclosure of most kinds of information about medical care was thought appropriate, though some patients indicated their preference for restricting discussion with third parties who were not close relatives ( Table 2) . Twenty-seven (90%) patients thought it was important for them to be asked about the sharing of their confidential information, but only six (20%) said that they would have initiated a discussion about this with their doctor if they had not been asked about it.
Discussion
This is a small study. Nevertheless, the results show that doctors do not frequently involve patients (with the capacity to decide) in decisions regarding sharing of their confidential information. The patients in this study were generally content for most of their confidential medical information to be shared with most groups (especially their children and spouses/partners). The issues of prognosis and resuscitation status may, however, be considered too personal by a proportion of patients to be shared with less close groups. This is germane, because patients believe it is important to be asked about, and involved in, any decisions regarding sharing of confidential information. Despite this, most of the patients in this study were reluctant to initiate such discussions with doctors. Despite the fact that doctors share confidential medical information on a regular basis with relatives we could find no previous studies addressing this issue in the care of older people. A number of studies have examined the importance of communication in other settings. Nelson et al. [5] reported a qualitative study of intensive care unit survivors. They found that, given the poor outcomes for most patients and high costs and burdens of treatment, effective communication between clinician, patient and the patient's family is essential when critical illness enters a chronic phase [5] . Hagerty et al. [6] examined the preferences of patients with incurable metastatic cancer with regard to the process of prognostic discussion. They concluded that the majority of patients preferred a realistic and individualised approach from the cancer specialist and detailed information when discussing prognosis [6] . Both of these reports support the trends revealed in our study.
The data in this study is limited by several factors. The sample size of 30 patients is small. Conclusions based on such small numbers must be guarded. Due to geographical location, the study population consisted predominantly of caucasian patients from a mainly Christian community. Older people of different ethnic and cultural backgrounds may present varying opinions regarding confidential information sharing. The patients included in the study were deemed cognitively intact on the basis of AMT >7/10 or MMSE >24/30. Psychometric tests are only a guide, not a substitute for a more detailed assessment of mental capacity. However, the cut-offs were chosen to be well above levels where patients' understanding of talking to their relatives and others about their condition would be likely to be impaired [7, 8] . The cognitive status of patients included is germane to our reliance on patients' reports of whether they had been asked about sharing of confidential information. Case note review revealed no documentation of any such discussions, though it remains a possibility that patients had forgotten them. Finally, the patients were interviewed directly by a doctor. This may have influenced their responses to the questions.
This study could be used as a basis for further work into the sharing of confidential information of cognitively intact older people. Any further work should have a larger sample size, incorporate patients from more diverse ethnic and cultural backgrounds, utilise more strict criteria on ensuring cognitive ability and consider the employment of health care professionals other than doctors to interview the patients.
Despite the limitations of this study, the general trend of results is clear. The patients in this study felt they should have been involved in decisions about sharing their confidential information. The overwhelming majority of these older patients stated that they had not been consulted about these decisions although most are content to share much of their confidential information with those closest to them. It is extremely important that doctors consider these views of cognitively intact older people and involve them more in the decision-making process. In particular, in view of the more sensitive issues of prognosis and resuscitation status, consideration could be given to the inclusion of an appropriately dedicated section in 'Do Not Attempt Resuscitation' forms. This could list those people that the cognitively intact older patient might wish to be kept informed of such a clinical decision. 
Prescription of paracetamol-containing medications as indicator of quality of prescribing
SIR-Paracetamol is widely prescribed for mild to moderate pain and pyrexia. It is available as a single ingredient and also in combination with opiate analgesics such as codeine and dihydrocodeine. The recommended dose of paracetamol for adults is 0.5 to 1 g every 4-6 h to a maximum of 4 g in a given 24-h period [1] .
Hepatotoxicity is rare if doses of paracetamol <12 g (or 150 mg/kg body weight) are ingested [2] although it is described [3, 4] . Patients with poor nutrition are particularly at risk of hepatotoxicity even at doses within the recommended range [5] . This may be relevant for older people in hospital as the prevalence of malnutrition is known to be high in this population [6] . However, we are not aware of clinical trial evidence to suggest that older people should have a lower recommended dose. In fact, the current recommended dose is not based on randomised controlled trial data. Using a single intravenous dose of 500 mg of paracetamol, Wynne et al. showed paracetamol clearance to decrease with age and frailty [7] . Miners et al. showed that after administering a single oral dose of 1 g of paracetamol the total clearance and clearance by glucuronidation did not change with age although there was a reduction in clearance by sulphation and renal clearance [8] . Interestingly there was no age effect on the cytochrome P450 mediated clearance of the reactive toxic metabolite. This has also been seen in rat studies [9] .
While deliberate overdose of paracetamol is well known, inadvertent, iatrogenic over-dosage is less well recognised. The National Sentinel Audit of Evidence Based Prescribing for Older People supported improvements in prescribing by measuring the quality of prescribing practice [10] . We report here on the prescription of paracetamol and paracetamolcontaining preparations in 102 hospitals that participated in the audit and give an estimate of the risk of exceeding the recommended dose of paracetamol. The data were collected prior to the withdrawal of Co-Proxamol, dextropropoxyphene in combination with paracetamol, withdrawn in January 2005, because of poorly established efficacy and unacceptable risk of toxicity in overdose [11] .
Methods
Hospitals in England and Wales were invited to volunteer to participate in the study in 1999 and 102 hospitals agreed. Prescribing data on paracetamol-containing medications were collected from drug charts of 100 consecutive medical inpatients aged 65 years or older on a selected day for each hospital. Data collected included the dose and frequency of all paracetamol containing medications prescribed. The total paracetamol content in milligrams prescribed to patients was evaluated over a 24 h period. We did not collect data on medications actually administered and nurses did not prescribe. Patients were considered to be at risk of overdosage if there was the potential to be administered over 4 g of paracetamol in 24 h.
Results
Data were collected for 9,979 patients. Of these, 9,927 patients had one or more drugs prescribed. Among these patients 6,141 (62%) were prescribed 6,560 medications
